Filgrastim Recruiting Phase 2 Trials for Acute Lymphocytic Leukemia (ALL) / Other Diseases of Blood and Blood-Forming Organs / Myelodysplastic Syndrome / Multiple Myeloma (MM) / Non-Hodgkin's Lymphoma (NHL) / Lymphoma, Hodgkins / Myeloproliferative Syndromes / Chronic Myeloid Leukemia (CML) / Leukemia Acute Myeloid Leukemia (AML) / Chronic Lymphocytic Leukaemia (CLL) Treatment

RecruitingTreatment2 IdentifierTitleDrugs
NCT03317899Stem Cell Transplant With or Without Tbo-filgrastim in Treating Patients With Multiple Myeloma or Non-Hodgkin Lymphoma
NCT02078102A Phase II Trial Using Meloxicam Plus Filgrastim in Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma
NCT03125642Auto Stem Cell Transplant for Lymphoma Patients
NCT03442673Chemotherapy and G-CSF for Mobilization
NCT02703779Exploratory Trial to Estimate Proportion of Patients With Tumor Cell Contaminated Leukapheresis Products With and Without Bortezomib With In-vivo Purging - Multiple Myeloma (MM)
NCT03188172MUK Nine b: OPTIMUM Treatment Protocol
NCT03356080DLAAG in the Treatment of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome With Blast Excess
NCT02782546Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation
NCT03045627Clinical Trial of Ara-C, Aclarubicin Combined With PEG-G-CSF for Initial Treatment of AML Patients
NCT02275663Azacytidine Plus FLAG for Relapsed or Refractory AML
NCT03646123Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma
NCT03755804Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17